Skip to main content

Part of the book series: Serono Symposia USA Norwell, Massachusetts ((SERONOSYMP))

  • 76 Accesses

Abstract

Growth hormone (GH) is an anabolic hormone that stimulates protein synthesis in normal volunteers. Although it also stimulates protein catabolism, the increase in protein synthesis is significantly greater than the concomitant increase in catabolism, resulting in net protein accretion. Two types of interventions have been used to induce catabolism in normal volunteers. These include caloric restriction and administration of glucocorticoids (1, 2). Normal volunteers who received high doses of prednisone to induce nitrogen loss responded to GH with significant improvement in nitrogen balance and an increase in nonoxidative leucine metabolism, which is an index of stimulation of protein synthesis (3). Similarly, several studies in calorically restricted normal volunteers have shown that GH results in protein conservation (4, 5).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clemmons DR, Snyder DK, Williams R, Underwood L. Treatment with growth hormone conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab 1987; 64: 878–83.

    Article  PubMed  CAS  Google Scholar 

  2. Horber FF, Haymond MW. Human growth hormone prevents protein catabolic side effects of prednisone in humans. J Clin Invest 1990; 86: 265–72.

    Article  PubMed  CAS  Google Scholar 

  3. Mauras N, Horber FF, Haymond MW. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but alters islet cell secretion in humans. J Clin Endocrinol Metab 1992: 1192–7.

    Google Scholar 

  4. Snyder DK, Clemmons DR, Underwood LE. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis and body composition. J Clin Endocrinol Metab 1988; 67: 54–61.

    Article  PubMed  CAS  Google Scholar 

  5. Snyder DK, Clemmons DR, Underwood LE. Dietary carbohydrate content determines responsiveness to growth hormone in humans. J Clin Endocrinol Metab 1989; 69: 745–52.

    Article  PubMed  CAS  Google Scholar 

  6. Jiang ZM, He GZ, Zhang SY. Low dose growth hormone and hypocaloric nutrition attenuate the protein catabolic response after major operation. Ann Surg 1989; 210: 513–25.

    Article  PubMed  CAS  Google Scholar 

  7. Ward HC, Halliday D, Sim AW. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987; 206: 56–61.

    Article  PubMed  CAS  Google Scholar 

  8. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990; 212: 424–31.

    Article  PubMed  CAS  Google Scholar 

  9. Sherran SK, Denling RH, LaLoude C, Erikson E, Wilmone RW. Growth hormone enhances re-epithelialization of human split thickness skin graft donor sites. Surg Forum 1993; 40: 37–9.

    Google Scholar 

  10. Zeigler TR, Young LS, Ferrari-Balivera E, Demling B, Wilmore EW. Use of growth hormone combined with nutritional support in the critical care unit. J Parenter Enteral Nutr 1990; 14: 574–81.

    Article  Google Scholar 

  11. Zeigler TR, Lazarus JM, Yough LS, Habeim R, Wilmore DW. Effects of recombinant growth hormone in adults receiving hemodialysis. J Am Soc Nephrol 1991; 2: 1130–5.

    Google Scholar 

  12. Zeigler TR, Bombeau JL, Young CS. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double blind, randomized controlled study. J Clin Endocrinol Metab 1992; 74: 865–73.

    Article  Google Scholar 

  13. Mulligan K, Grunfeld C, Hellerstin MK, Neese RA, Scheinbelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993; 77: 956–63.

    Article  PubMed  CAS  Google Scholar 

  14. Pape GS, Freidman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991; 99: 1495–500.

    Article  PubMed  CAS  Google Scholar 

  15. Kelly PA, Djiane J, Postel-Vinay MC, Edery JC. The prolactin/growth hormone receptor family. Endocr Rev 1991; 12: 235–51.

    Article  PubMed  CAS  Google Scholar 

  16. Bazan JF. Structural design and molecular evolution for cytokine receptor super family. Proc Natl Acad Sci USA 1990; 87: 6934–8.

    Article  PubMed  CAS  Google Scholar 

  17. Costin G, Kogut MD, Frasier SD. Effect of low-dose human growth hormone on carbohydrate metabolism in children with hypopituitarism. J Pediatr 1972; 80: 796–803.

    Article  PubMed  CAS  Google Scholar 

  18. Belcher HJCR, Mercer D, Judkins KC. Biosynthetic human growth hormone in burned patients: a pilot study. Burns 1989;15:99–107.

    Google Scholar 

  19. Roberts CT, Brown AO, Graham DE, et al. Growth hormone regulates the abundance of insulin-like growth factor-I RNA in adult rat liver. J Biol Chem 1986; 261: 10025–8.

    PubMed  CAS  Google Scholar 

  20. Turkalj I, Keller N, Ninnis R, Vossner S, Stauffecker W. Effect of increasing doses of recombinant insulin-like growth factor on glucose, lipid and leucine metabolism. J Clin Endocrinol Metab 1993; 75: 1186–91.

    Article  Google Scholar 

  21. Jacob RJ, Nederostek D, Wong L. Low doses of IGF-I stimulate muscle protein synthesis in anabolic rats if hypoaminoacidemia is prevented [Abstract #655]. Annu meet Endocr Soc, Las Vegas, NV, June 14–16, 1993.

    Google Scholar 

  22. Clemmons DR, Smith-Banks A, Celniker AC, Underwood LE. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I (IGF-I) in humans. J Clin Endocrinol Metab 1992; 75: 234–8.

    Article  PubMed  CAS  Google Scholar 

  23. Young SCJ, Smith-Banks A, Underwood LE, Clemmons DR. Effects of recombinant IGF-I and GH treatment upon serum IGF binding proteins in calorically restricted adults. J Clin Endocrinol Metab 1992; 75: 603–8.

    Article  PubMed  CAS  Google Scholar 

  24. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-I by the use of both agents simultaneously. J Clin Invest 1993; 91: 391–7.

    Article  PubMed  CAS  Google Scholar 

  25. Hussein MA, Schmitz O, Menge CA. Effects of growth hormone and insulin-like growth factor I on body fuel metabolism and insulin sensitivity in GH deficient humans [Abstract #1595]. 75th annu meet Endocr Soc, Las Vegas, NV, June 14–16, 1993.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag New York, Inc.

About this paper

Cite this paper

Clemmons, D.R. (1995). Growth Hormone and IGF-I as Anabolic Partitioning Hormones. In: Adashi, E.Y., Thorner, M.O. (eds) The Somatotrophic Axis and the Reproductive Process in Health and Disease. Serono Symposia USA Norwell, Massachusetts. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2518-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2518-8_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7567-1

  • Online ISBN: 978-1-4612-2518-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics